LABZ — Metasphere Labs Income Statement
0.000.00%
- CA$0.88m
- CA$0.83m
- CA$0.00m
Annual income statement for Metasphere Labs, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2021 July 31st | R2022 July 31st | 2023 July 31st | 2024 July 31st | 2025 July 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 7.01 | 0.655 | 2.2 | 0.003 |
| Cost of Revenue | |||||
| Gross Profit | — | 6.28 | 0.545 | 1.84 | 0 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.053 | 19.7 | 13 | 2.22 | 1.01 |
| Operating Profit | -0.053 | -12.7 | -12.4 | -0.02 | -1.01 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.053 | -12.9 | -12.4 | -0.014 | -0.91 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.053 | -11.7 | -12.4 | -0.014 | -0.91 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -0.053 | -12.1 | -12.5 | -0.014 | -0.91 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.053 | -12.1 | -12.5 | -0.014 | -0.91 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.146 | -25.4 | -12.2 | 0.108 | -0.083 |